skip to main content

H.R. 3: Lower Drug Costs Now Act of 2019

Call or Write Congress

To establish a fair price negotiation program, protect the Medicare program from excessive price increases, and establish an out-of-pocket maximum for Medicare part D enrollees, and for other purposes.

The bill’s titles are written by its sponsor.

Sponsor and status

Frank Pallone Jr.

Sponsor. Representative for New Jersey's 6th congressional district. Democrat.

Read Text »
Last Updated: Sep 19, 2019
Length: 101 pages
Sep 19, 2019

Ordered Reported on Oct 17, 2019

The committees assigned to this bill sent it to the House or Senate as a whole for consideration on October 17, 2019.

The House Majority Leader indicated on Dec 6, 2019 that this bill may be considered in the week ahead.

69% chance of being enacted according to Skopos Labs (details)

Position statements

What legislators are saying

Congresswoman Schakowsky Announces Inclusion of Her Lymphedema Treatment Act In H.R. 3
    — Rep. Janice “Jan” Schakowsky [D-IL9] (Co-sponsor) on Dec 5, 2019

Rep. Cartwright Statement on Upcoming Vote to Lower Drug Costs for Americans
    — Rep. Matthew Cartwright [D-PA8] (Co-sponsor) on Dec 5, 2019

From the White House: House Drug Pricing Bill Could Keep 100 Lifesaving Drugs from American Patients
    — Rep. Larry Bucshon [R-IN8] on Dec 3, 2019

More statements at ProPublica Represent...


Sep 19, 2019

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Sep 25, 2019
Considered by Health

A committee held a hearing or business meeting about the bill.

Oct 17, 2019
Ordered Reported

A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

Oct 22, 2019
Considered by House Committee on Ways and Means

A committee held a hearing or business meeting about the bill.

Dec 6, 2019
On House Schedule

The House indicated that this bill would be considered in the week ahead.

If this bill has further action, the following steps may occur next:
Passed House

Passed Senate

Signed by the President

H.R. 3 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 3 — 116th Congress: Lower Drug Costs Now Act of 2019.” 2019. December 8, 2019 <>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from, the official portal of the United States Congress. is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.